• Thalocan
  • Lesion Area
  • Mapping Assistant
  • Patent Pending
  • Expert Guidance
  • on the clinical
  • endpoint
  • landspace
  • Thalocan Assessment
  • Validation Online System
  • Extensive disease
  • state photo library
  • and custom
  • 3D animations
  • The First eCOA
  • specifically built
  • for dermatology
  • Training authored by
  • globally recognized KOLs

Thalocan is revolutionizing the clinical assessment of dermatological diseases with cutting-edge tools designed to enhance every stage of the clinical trial process. Our solutions address common issues that delay trials, ensuring faster and more accurate endpoint data capture.
KEY BENEFITS INCLUDE:

Trialists can collect precise
endpoint data more efficiently.
Patient experience during
study visits is significantly improved.
Medical monitors gain unprecedented
real-time access to study data.

Our mission is the continuous improvement of clinical endpoint data and the simplification of navigating the study endpoint scale landscape,
empowering researchers to optimize trial outcomes and streamline operations.

null

Consulting

TRI provides consulting services for endpoint scale management.
Learn more
null

Disease State Image Sourcing

TRI draws from our extensive library of disease state images to license for use in clinical research instruction.
Learn more
null

Scale Development and Validation

TRI has experience supporting scale development and validation.
Learn more
null

Scale Training

TRI has a deep background creating disease state and rater scale training for Sponsors and CROs as well as scientific organizations.
Learn more
null

Scale Administration

A powerful eCOA platform designed for maximum flexibility and unprecedented speed of deployment.
Learn more
null

Lesion Mapping Assistant

A one-of-a-kind support tool for dermatologists.
Learn more